Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
716
-91
-11% -$29.7K 0.01% 367
2026
Q1
$263K Sell
807
-5
-0.6% -$1.6K 0.01% 344
2025
Q4
$253K Sell
812
-94
-10% -$27.5K 0.01% 344
2025
Q3
$256K Sell
906
-10
-1% -$2.75K 0.01% 340
2025
Q2
$265K Sell
916
-8
-0.9% -$2.3K 0.01% 311
2025
Q1
$279K Buy
924
+11
+1% +$3.06K 0.01% 290
2024
Q4
$252K Sell
913
-33
-3% -$9.37K 0.01% 301
2024
Q3
$273K Sell
946
-97
-9% -$26.6K 0.01% 288
2024
Q2
$266K Buy
+1,043
New +$268K 0.01% 284

Other funds holding CB

Trilogy Capital's CB Position: Q2 2026 in Review

Trilogy Capital reduced its Chubb (CB) stake by 11% in Q2 2026, selling an estimated $29.7K and leaving 716 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #367.

Trilogy Capital first reported a position in CB in Q2 2024 and has held it in 9 quarters since. The position peaked at $279K in Q1 2025. 354 funds tracked by Wall St. Rank hold CB as of Q2 2026.

  • Trilogy Capital held 716 shares of Chubb worth $244K as of Q2 2026.
  • Trilogy Capital sold 91 Chubb shares in Q2 2026, an estimated $29.7K.
  • Chubb made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #367 holding.
  • Trilogy Capital first reported a position in Chubb in Q2 2024 and has held it in 9 quarters since.
  • Trilogy Capital's Chubb position peaked at $279K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Chubb as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.